U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Intensive Nutrition Incorporated - 395974 - 10/09/2018
  1. Warning Letters

CLOSEOUT LETTER

Intensive Nutrition Incorporated MARCS-CMS 395974 —

Product:
Dietary Supplements
Recipient:
Recipient Name
Olivia B. Melaugh
Recipient Title
President
Intensive Nutrition Incorporated
Intensive Nutrition Incorporated

1972 Republic Ave.
San Leandro, CA 94577-4224
United States

Issuing Office:
OHAFO West Division 5

1431 Harbor Bay Parkway
Alameda, CA 94502
United States

October 9, 2018

RE: WL Close-Out Letter

Dear Ms. Melaugh:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, dated January 22, 2014. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Sergio Chavez
Director Compliance Branch
Food and Drug Administration
HAF Division West 5

Back to Top